Moderna - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Moderna, a US-based biotechnology company, hopeful of cancer vaccine by 2030

Moderna in $35 million licensing deal with CytomX

Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.

by HealthQuill
January 7, 2023
0 Comments

Drugs Medical Pharma

Pfizer expected to charge quadruple for Covid vaccines in the US

Pfizer set to increase Covid-19 vaccine prices by almost four times in the US

by HealthQuill
October 25, 2022
0 Comments

Drugs Pharma

Gavi, Moderna sign pact for Covid-19 vaccines

HQ Team October 18, 2022: Gavi, a public-private partnership Vaccine Alliance, has signed a new pact with Moderna to supply Covid-19 vaccines to low-income countries..